Chris Jones is Chief Ventures Investment Officer at the University of Vermont Health Network (UVMHN), where he leads a mission-driven ventures fund. The mission of this fund is to invest in opportunities that accelerate the provision of excellent care to patients, as well as provide new opportunities for improved access to care and wider community impact. Prior to joining this captive venture fund, Chris was a professor-entrepreneur in the UVM College of Medicine where he taught health economics. There he founded an award-winning behavioral change company called trUStr.US. Prior to his academic time, Chris held various roles in pharma and government including in global commercial development for CSL Behring, Inc, and as a member of the Guideline Development Group for the National Institute for Health and Clinical Excellence, based in London. Chris is an active early-stage investor, and a judge for various venture competitions, including Vizient (USA) and NETVA (France). Chris coined the term Intelligent Patient Reported Outcomes (iPROs) and is Affiliate Faculty in the Department of Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy. He is an elected voting member of the New England Comparative Effectiveness Public Advisory Council. Chris graduated with a degree in literature, science and the arts from the University of Michigan. A recipient of the Bertarelli Research Prize of Switzerland and Overseas Research Studentship awarded by the British Government, Chris also earned his MSc in human biology and DPhil in economics from Oxford University. His dissertation was the first to optimize in-vitro fertilization procedures in light of costs and multiple birth outcomes. In sports, Chris was a college rower (Christ Church) and ski captain for the Val d’Isere Oxford-Cambridge Varsity Race. Living in Vermont, Chris enjoys spending time with his children, skiing, and restoring vintage cars.